Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 95: 81-88, 2003. First published March 7, 2003; doi:10.1152/japplphysiol.00119.2003
8750-7587/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
95/1/81    most recent
00119.2003v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodríguez-Sinovas, A.
Right arrow Articles by Cinca, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodríguez-Sinovas, A.
Right arrow Articles by Cinca, J.

Coronary smooth muscle reactivity to muscarinic stimulation after ischemia-reperfusion in porcine myocardial infarction

Antonio Rodríguez-Sinovas, Josep Bis, Inocencio Anivarro, Javier de la Torre, Antoni Bayés-Genís, and Juan Cinca

Laboratory of Cardiovascular Physiology, Vall d'Hebron Hospitals, and Cardiology Service, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, 08025 Barcelona, Spain

Submitted 4 February 2003 ; accepted in final form 3 March 2003


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
This study tested whether ischemia-reperfusion alters coronary smooth muscle reactivity to vasoconstrictor stimuli such as those elicited by an adventitial stimulation with methacholine. In vitro studies were performed to assess the reactivity of endothelium-denuded infarct-related coronary arteries to methacholine (n = 18). In addition, the vasoconstrictor effects of adventitial application of methacholine to left anterior descending (LAD) coronary artery was assessed in vivo in pigs submitted to 2 h of LAD occlusion followed by reperfusion (n = 12), LAD deendothelization (n = 11), or a sham operation (n = 6). Endothelial-dependent vasodilator capacity of infarct-related LAD was assessed by intracoronary injection of bradykinin (n = 13). In vitro, smooth muscle reactivity to methacholine was unaffected by ischemia-reperfusion. In vivo, baseline methacholine administration induced a transient and reversible drop in coronary blood flow (9.6 ± 4.6 to 1.9 ± 2.6 ml/min, P < 0.01), accompanied by severe left ventricular dysfunction. After ischemia-reperfusion, methacholine induced a prolonged and severe coronary blood flow drop (9.7 ± 7.0 to 3.4 ± 3.9 ml/min), with a significant delay in recovery (P < 0.001). Endothelial denudation mimics in part the effects of methacholine after ischemia-reperfusion, and intracoronary bradykinin confirmed the existence of endothelial dysfunction. Infarct-related epicardial coronary artery shows a delayed recovery after vasoconstrictor stimuli, because of appropriate smooth muscle reactivity and impairment of endothelial-dependent vasodilator capacity.

arteries; receptors; methacholine; cholinergic agonists


ACHIEVING PATENCY OF AN OCCLUDED coronary artery is a major therapeutic goal in patients presenting with acute myocardial infarction. Fibrinolytic agents or acute interventional procedures attempt to restore coronary blood flow through the occluded coronary vessel and ultimately reduce the size of the infarcted area. Restoration of coronary blood flow in an acutely occluded coronary artery causes endothelial dysfunction, manifested as an alteration of endothelial-dependent vasodilation (12, 16, 21, 27, 32). Reperfused coronary arteries may also depict an abnormal smooth muscle function. The existing data in this regard are controversial. Indeed, canine coronary artery rings preexposed to 10–30 min of ischemia and reperfusion showed higher increases in tension to KCl than control arteries (16). In contrast, in isolated rat hearts, the contractile response to KCl, U-46619, and serotonin was depressed for at least 15 min after 15 min of global ischemia (11).

During the acute phase of myocardial infarction, some patients may present episodes of recurrent ischemia. Postinfarction angina is a serious clinical condition with a potentially unfavorable outcome due to progression of the ischemic process, leading to reinfarction or increased mortality (4, 8, 15). The mechanism of postinfarction angina is not fully understood. In most instances, rethrombosis of the culprit plaque has been documented (1, 28). However, in other circumstances, an increase in coronary reactivity has been alluded (3, 9, 23, 26). In this regard, it is not known whether the infarct-related coronary artery may react in a normal fashion to vasoconstrictor stimuli elicited in the acute phase of myocardial infarction.

The aim of this work was to analyze whether ischemia-reperfusion alters coronary smooth muscle reactivity to vasoconstrictor stimuli such as those elicited by an adventitial muscarinic stimulation with methacholine. Possible mechanisms of the observed in vivo dysfunction were also studied.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Reactivity of infarct-related epicardial coronary artery was analyzed both in vitro and in vivo in hybrid pigs of either sex, aged 3–4 mo (30–40 kg). This investigation conforms with the "Guide for the Care and Use of Laboratory Animals" published by the National Institutes of Health (NIH Publication No. 85-23, revised 1996). The study was approved by the Ethics Committee of our institution.

In Vitro Studies

Eighteen pigs were submitted to a midsternotomy under sodium thiopental anesthesia (30 mg/kg iv) preceded by azaperone (1–2 mg/kg im). In 6 of the 18 pigs, the left anterior descending (LAD) coronary artery was occluded below the first diagonal branch for a period of 2 h followed by 45 min of reperfusion (study group), whereas in the remaining 12 pigs the coronary artery was not occluded (control group). The hearts were removed, and the LAD was dissected and placed in oxygenated (95% O2-5% CO2) Krebs solution at 4°C (in mM: 120 NaCl, 4.7 KCl, 2.5 CaCl2, 1.2 KH2PO4, 1.2 MgSO4, 25 NaHCO3, and 10 glucose; pH 7.4). The LAD was divided in three thirds (proximal, middle, and distal), and two rings (3–4 mm width) were taken from each third to assess regional differences in coronary reactivity. LAD rings above the site of the ligature were excluded from the study. In all cases, the endothelium was removed by rubbing the luminal coronary surface with a thin forceps, and denudation was verified by histological examination. Coronary rings were placed in 10-ml organ baths containing oxygenated Krebs solution at 37°C and were connected to horizontal force transducers (FSG-01, Experimetria, London, UK). Changes in tension were amplified (SG-M DC bridge amplifier module, Experimetria) and stored in a computer for later analysis. All rings were equilibrated at a resting tension of 2 g for 1 h. Tissues were contracted three or four times with 40 mM KCl, every 10 min, until the amplitude of the contractile response was similar in magnitude (29). Constriction concentration-response curves to methacholine (10-8 to 10-5 M, spaced 30 min) were studied in rings from all 18 pigs. Methacholine chloride was obtained from Sigma Chemical (St. Louis, MO) and dissolved in saline.

Data analysis. Changes in tension induced by methacholine were expressed as percentage of the contraction to KCl 40 mM. Response of duplicate rings of the same coronary segment was averaged. Data were fitted to a sigmoid function to determine the maximal effect (Emax) and the concentration of agonist necessary to produce half-maximal response (EC50 value). All values are expressed as means ± SD. Tension responses induced in the three coronary thirds of control pigs were compared by use of the ANOVA and Tukey's tests. Differences in Emax and EC50 between control and ischemic-reperfused rings were assessed by Student's t-test.

In Vivo Studies

Forty-two pigs were submitted to a midsternotomy under general anesthesia with {alpha}-chloralose (100 mg/kg iv) preceded by premedication with azaperone (1–2 mg/kg im) and sodium metomidate (4 mg/kg iv) or sodium thiopental (7–9 mg/kg iv). Pulmonary ventilation was maintained with a pressure respirator. The thorax was opened through a midsternotomy, and the heart was exposed. In experimental series 1 (29 pigs), we assessed LAD reactivity to adventitial methacholine. In these cases the LAD was looped below the first diagonal branch with a 3-0 silk snare, and two dissections were made, respectively, at 10 and 15 mm below the occluding snare. The upper dissection was used for adventitial muscarinic stimulation with 1% methacholine, and the lower dissection allowed placement of a coronary blood flow probe (5, 6). In experimental series 2 (13 pigs), we assessed the endothelial-dependent vasodilator response induced by intracoronary administration of bradykinin (22). A small diagonal branch of the LAD was cannulated by use of a 24G Abbocath-T (Venisystems, Abbott, Sligo, Ireland), and the tip of the cannula was gently introduced into the lumen of the LAD to administer bradykinin. A 3-0 silk snare was placed around the LAD, just below the catheterized arterial branch, and flow measurements were performed 10 mm distal to the occluding snare. Conventional ECG was recorded with a seven-channel Elema ink-jet polygraph (Mingograf 710 System, Siemens, Sweden). Left ventricular (LV) pressure and LV change in pressure over time (dP/dt) were measured with a Millar SPC-350 catheter transducer (Millar Instruments, Houston, TX). Blood flow at the LAD and aortic root were measured with ultrasonic probes (Transonic T206, Transonic Systems, Ithaca, NY). Regional myocardial shortening at the apical and basal regions of the LV was assessed by ultrasonic crystals (System 6, Triton Technology, San Diego, CA) as described elsewhere (5, 6). All signals were recorded in a thermal-array Nihon Kohden RTA 1200 polygraph and digitally stored for later analysis.

Study protocol. EXPERIMENTAL SERIES 1 (METHACHOLINE). Pigs included in this series underwent two 15-s methacholine applications to the adventitia of the LAD, by use of a 5-mm2 piece of gauze soaked in 1% methacholine chloride, spaced 3 h. In this model, methacholine adventitial application induces a marked and reproducible reduction in coronary blood flow due to a severe local vasoconstriction as denoted by coronary angiography (5).

The following subsets of animals were created. 1) Sham methacholine controls (group 1a, n = 6): no maneuvers were performed between the two methacholine applications. 2) In group 1b, the second methacholine test was performed after 2-h occlusion and 45 min reperfusion of the LAD to analyze reactivity of infarct-related coronary artery to muscarinic stimulation. 3) Deendothelization (group 1c, n = 11): The second methacholine test was performed after LAD endothelial denudation to assess the role of endothelium in the coronary response to methacholine. Endothelial denudation was provoked by a 3.5-Fr shaft angioplasty catheter with a balloon of 3.5-mm diameter and 20-mm length (Schneider Europe) introduced percutaneously under X-ray control. The balloon was inflated at 10 atm and then withdrawn for the entire coronary artery length. Deendothelization procedure lasted always 30–40 s. Endothelial denudation was confirmed by histological examination.

EXPERIMENTAL SERIES 2 (BRADYKININ). Pigs included in this series were used to verify that LAD occlusion (2 h) and reperfusion (45 min) caused endothelial dysfunction in this model. Bradykinin has been shown to induce an endothelial-dependent vasodilation (22) and thus is a good tool to assess the functional integrity of endothelium. Two subgroups were created. 1) sham bradykinin controls (group 2a, n = 5): two intracoronary injections of bradykinin (0.2 ml of a 3 x 10-6 M solution, dissolved in 0.9% NaCl) were administered as previously described (22), spaced 3 h but with no occlusion of the LAD. 2) Coronary occlusion (group 2b, n = 8): reactivity of the LAD to bradykinin was analyzed before and after 2-h occlusion-45 min reperfusion.

To exclude active effects of the bradykinin solution vehicle, 0.2 ml of 0.9% sodium chloride solution were injected in all 13 pigs to the LAD. Moreover, the systemic effects of 0.2 ml of 3 x 10-6 M of bradykinin injected in the femoral vein were tested in four pigs of group 2a at the end of the experiment.

Data analysis. Changes in heart rate, ST segment potential in ECG lead V1, LV systolic pressure (LVSP), LV end-diastolic pressure (LVEDP), peak (+) and (-) of the LV dP/dt, mean blood flow at the LAD and aortic root, and systolic segment shortening ratio induced by methacholine or bradykinin, before and after each maneuver, were compared by repeated-measures ANOVA test. These variables were analyzed on samples taken at baseline and at 120, 180, 240, and 300 s after methacholine application, or at baseline and at 25, 35, 45, and 80 s after bradykinin administration. To better assess the sequential coronary blood flow changes induced by methacholine, the early vasoconstrictor phase was assessed at baseline and at 30, 60, 90, and 120 s, whereas the ensuing recovery phase was evaluated at baseline and at 60, 270, 300, and 330 s. Similarly, coronary blood flow changes induced by bradykinin were assessed at baseline and at 15, 20, 25, and 40 s for the early vasodilator response and at baseline and at 40, 70, 120, and 180 s for the latest. Baseline values before and after each maneuver were compared by Student's t-test. Data are expressed as mean ± SD. A P value < 0.05 was considered significant.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
In Vitro Coronary Reactivity

Effects of methacholine. Stimulation of control rings with 40 mM KCl induced higher increases in tension as we moved in the proximal direction in the coronary artery (1.88 ± 0.55, 1.39 ± 0.54 and 0.93 ± 0.44 g in proximal, middle and distal rings, respectively, ANOVA, P < 0.001). Despite this higher response to KCl, the methacholine Emax in all three segments was similar (83 ± 21, 89 ± 39, and 101 ± 41% in proximal, middle, and distal, respectively), suggesting that the same proportion of muscarinic receptors is present in all areas. All coronary rings showed a concentration-dependent increase in tension after exposure to methacholine. In contrast with Emax values, proximal LAD segments of the 12 control pigs showed a significantly lower EC50 (8.0 ± 2.5 x 10-7 M, ANOVA, P < 0.05) than middle (1.2 ± 0.4 x 10-6 M) and distal (1.3 ± 0.5 x 10-6 M) coronary segments.

Data from middle and distal segments with similar reactivity to methacholine were pooled and used to assess the reactivity of coronary rings preexposed to ischemia-reperfusion. LAD regions above the ligature were not analyzed. LAD arteries from six pigs submitted to coronary occlusion and reperfusion showed a similar response to methacholine to those from 12 control animals (Fig. 1). In addition, no changes in the response to 40 mM KCl were observed in rings previously submitted to ischemia-reperfusion (1.20 ± 0.55 and 1.08 ± 0.47 g in control and ischemic-reperfused segments, respectively).



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1. Concentration-dependent changes in tension induced by methacholine in endothelium-denuded left anterior descending (LAD) rings both in control conditions ({bullet}) and after preexposure to ischemia-reperfusion ({square}).

 

In Vivo Coronary Reactivity

Our in vitro results did not show differences in reactivity after muscarinic stimulation between endothelium-denuded controls and infarct-related coronary arteries. We then evaluated the integrity of vascular smooth muscle reactivity in an in vivo situation that mimics early coronary reperfusion and endothelial dysfunction in patients with acute myocardial infarction.

Experimental series 1 (methacholine). SHAM METHACHOLINE CONTROLS (GROUP 1A). LAD adventitial methacholine application was followed by a marked drop in regional coronary blood flow associated with depression of LV hemodynamic parameters and abnormal regional myocardial shortening in the region perfused by the LAD. Figure 2 shows a representative recording showing the effects of methacholine in baseline conditions. The methacholine-induced reduction in coronary blood flow was accompanied by a 12% drop in LVSP, 25% fall in LV (+)dP/dt, 23% reduction in LV (-)dP/dt, and 80% attenuation of regional segment shortening in the apical region. These changes were associated with small increases in heart rate and with ST segment elevation. Methacholine did not induce appreciable changes in aortic blood flow, LVEDP, or regional segment shortening in the proximal region. The second methacholine test in the six sham control pigs induced comparable LV hemodynamic changes.



View larger version (34K):
[in this window]
[in a new window]
 
Fig. 2. Computer-generated recordings showing the effects of the first adventitial application of 1% methacholine to the LAD, in a sham control pig (group 1a), on ECG lead V1, systolic shortening in proximal and apical regions of the left ventricle (LV), LV pressure (LVP), LV change in pressure over time (dP/dt), and blood flow at the LAD (CBF) and at the aortic root (ABF).

 

As depicted in Fig. 3A, sham controls showed a reduction of coronary blood flow from 7.7 ± 1.5 to 0.6 ± 1.5 ml/min (ANOVA, P < 0.01), which recovered spontaneously 4–5 min after drug application, giving rise to an hyperemic reaction (16.7 ± 7.0 ml/min). The second methacholine application performed 3 h later induced a similar coronary blood flow reduction (from 8.2 ± 2.5 to 0.5 ± 0.5 ml/min) and a comparable hyperemic reaction (19.5 ± 8.4 ml/min).



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3. CBF changes induced by the first ({bullet}) and the second ({circ}) adventitial applications of 1% methacholine to the LAD in 6 sham control pigs (A), in 12 pigs submitted to 2h of LAD occlusion followed by reperfusion (B), and in 11 pigs submitted to endothelial denudation with an angioplasty balloon (C). Notice the long-lasting recovery of CBF changes after ischemia-reperfusion. P < 0.05, significant differences in the time course of the changes in CBF induced by methacholine between the first and second drug exposures. NS, not significant.

 

REACTIVITY OF INFARCT-RELATED CORONARY ARTERY TO METHACHOLINE (GROUP 1B). Pigs submitted to 2 h LAD occlusion followed by reperfusion, thus having acute myocardial infarction, showed a recovery of the hemodynamic variables but regional systolic shortening at the LV apical region remained severely depressed (Fig. 4). The effects of the first methacholine test on LAD coronary blood flow were comparable to those induced in the sham group (Fig. 3B). Coronary blood flow decreased from 9.6 ± 4.6 to 1.9 ± 2.6 ml/min (ANOVA, P < 0.01), and this was followed by an hyperemic reaction (17.9 ± 8.0 ml/min). Adventitial application of methacholine to the infarct-related coronary artery induced a severe and persistent coronary blood flow decay but with a significantly delayed recovery (P < 0.001) and no appreciable hyperemic reaction (Fig. 3B). Heart rate and LV-derived changes induced by methacholine application after ischemia-reperfusion were comparable to those elicited by the first methacholine test (Fig. 4).



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4. Changes in heart rate (A), apical regional shortening (B), LV systolic pressure (LVSP; C), LV dP/dt (D), and ABF (E) induced by adventitial application of 1% methacholine to the LAD at baseline ({bullet}) and after ischemia-reperfusion ({circ}) in pigs from group 1b. P < 0.05, significant differences in the time course of the changes induced by methacholine between the first and second drug exposures.

 

During coronary occlusion, 6 of 12 pigs developed episodes of ventricular fibrillation (VF), which were terminated by internal direct-current countershocks of 15 W/s. Cardioversion did not modify the response to methacholine after ischemia-reperfusion, with no hyperemic reaction in any case (from a baseline flow of 11.2 ± 6.9 ml/min to a maximal postmethacholine flow of 9.83 ± 6.8 ml/min in animals with VF, and from 8.2 ± 7.6 to 6.4 ± 5.1 ml/min in animals without VF).

REACTIVITY OF ENDOTHELIUM-DENUDED CORONARY ARTERY TO METHACHOLINE (GROUP 1C). As shown in Fig. 3C, baseline coronary blood flow was not affected by the deendothelization maneuver. Methacholine application to endothelium-denuded LAD showed a similar vasoconstriction as previously described and a significantly reduced hyperemic reaction (ANOVA, P = 0.035).

Experimental series 2 (bradykinin). SHAM BRADYKININ CONTROLS (GROUP 2A). Figure 5A shows that LAD bradykinin injection induced a marked increase in coronary blood flow (ANOVA, P < 0.01) with a biphasic pattern: a first peak was reached after 20 s and a second peak value was achieved 60–80 s after bradykinin administration. Significant changes in LV parameters were observed 25–45 s after bradykinin administration. These included a 6% reduction in LV pressure (P < 0.05), 24% decrease in LV (-)dP/dt, 13% drop in LVEDP (P < 0.05), 12% increase in LV (+)dP/dt (P < 0.01), 7% increase in heart rate (P < 0.05), 15% increase in aortic blood flow (P < 0.05), and 9% augmentation of systolic segment shortening in the LV apical region (P < 0.05). The second bradykinin test performed 3 h later in the five sham control pigs induced a similar biphasic increase in coronary blood flow (first peak, 168 ± 155%; second peak, 188 ± 96%) (Fig. 5A).



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5. CBF changes induced by the first ({bullet}) and the second ({circ}) intracoronary administrations of bradykinin into the LAD in 5 sham control pigs (A) and in 8 pigs submitted to 2 h of LAD occlusion followed by reperfusion (B). P < 0.05, significant differences in the time course of the changes in CBF induced by bradykinin between the first and second drug administrations.

 

Intracoronary administration of 0.9% sodium chloride solution did not induce significant effects. Intravenous administration of bradykinin caused a significant (P < 0.05) decrease in coronary blood flow, LV pressure, and LV dP/dt and an increase in aortic blood flow and systolic segment shortening at both apical and basal LV regions. The trend of this hemodynamic response is comparable to that observed 25–45 s after intracoronary bradykinin administration, thus suggesting that the late hemodynamic effects observed after an intracoronary bradykinin administration may reflect systemic actions of the peptide.

REACTIVITY OF INFARCT-RELATED CORONARY ARTERY TO BRADYKININ (GROUP 2B). Compared with the baseline test, intracoronary administration of bradykinin into the infarct-related coronary artery only induced a mild increase in coronary blood flow (52 ± 34 vs. 180 ± 149%, P < 0.001) (Fig. 5B). The two bradykinin injections induced comparable changes in heart rate and LV-derived parameters.

During coronary occlusion, five of eight pigs developed episodes of VF, which were terminated by internal direct-current countershocks of 15 W/s. As occurred in methacholine group 1b, cardioversion did not modify the response to bradykinin after ischemia-reperfusion.


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
This study shows that infarct-related coronary arteries develop a prolonged vasoconstriction after stimulation with the muscarinic agonist methacholine. Such prolonged vasoconstrictor response appears to be related to preservation of the smooth muscle function and impairment of endothelium-dependent vasodilation.

Coronary arteries exposed to reversible interruption of coronary blood flow show endothelial function impairment as denoted by their attenuated response to the endothelium-dependent vasodilator substances acetylcholine (7, 18, 21, 22, 24, 27, 32), ADP (12, 24), or bradykinin (12, 16, 22). The endothelial dysfunction appears to be caused by oxygen-derived free radicals released during the reperfusion period (31) and may contribute to the incompetence of the microvasculature to reperfuse the myocardium ("no reflow" phenomenon) (13, 17). Most of the studies analyzing the effects of ischemia-reperfusion on coronary vascular function have focused on the endothelium, and the involvement of other vascular structures such as the smooth muscle has been ill defined.

Studies analyzing the intrinsic reactivity of coronary smooth muscle after ischemia-reperfusion have not afforded conclusive data. It has been reported that coronary arteries preexposed to ischemia-reperfusion depict a normal response to endothelium-independent vasodilators like NO donors, adenosine, or isoproterenol (12, 16, 24, 32), but others have found an attenuated vasodilation after in vivo exposure to endothelial-independent papaverine (2). These differences may be due to the fact that in most studies it is not possible to subtract the net effects caused by the simultaneous exposure of the endothelium to the drug. Indeed, the increased vasoconstrictor effect induced by KCl in some studies (12, 16, 32), although not in others (11, 24), has been attributed to the presence of endothelial dysfunction leading to a diminished release of endothelium-derived vasodilators (12, 16, 32). In favor of the role of the endothelial function, coronary rings devoid of endothelium develop a comparable response to KCl before and after exposure to ischemia (16, 24).

The present study delineates the effects of ischemia-reperfusion on coronary smooth muscle reactivity both in vivo and in vitro in a model that avoids simultaneous stimulation of endothelium. Adventitial application of methacholine induces a specific muscarinic-mediated local constriction of the coronary artery in pigs, as denoted by its inhibition with atropine and by interruption of flow at angiography (5). In the in vivo model, we assessed the reactivity of conduit coronary arteries to adventitial muscarinic stimulation with methacholine before and after 2 h of ischemia followed by reperfusion in the same preselected coronary segment, mimicking the pathophysiological condition of an infarct-related coronary artery exposed to a heightened cardiac parasympathetic neural drive. Our in vitro data evidence similar responses to methacholine and KCl in both control and ischemic-reperfused endothelium-denuded rings. In addition, our in vivo data reveal that methacholine application to the LAD induces a severe coronary vasoconstriction leading to a virtual cessation of coronary blood flow, both at baseline conditions and after 2 h of LAD ligature followed by 45 min of reperfusion. Thus both in vivo and in vitro data demonstrate that smooth muscle reactivity is not affected in infarct-related coronary artery. However, in vivo we observed that blood flow recovery after methacholine administration in infarct-related coronary artery was markedly delayed and was not accompanied by an hyperemic reaction as occurred during the preischemic baseline methacholine test. In light of these findings, it is possible to speculate that imbalance between sympathetic and parasympathetic nervous systems after myocardial infarction may play a significant role in the genesis of postinfarction angina. Our data support a prolonged effect of muscarinic stimulation after ischemia-reperfusion.

The well-known loss of endothelial-dependent relaxation reported in other studies after ischemia-reperfusion (12, 13, 16, 18, 22, 27) may theoretically render the infarct-related coronary artery less prone to recover from vasoconstrictor stimuli. Indeed, in this study we have confirmed the existence of endothelial dysfunction after exposure of the LAD to reversible coronary occlusion because the coronary blood flow response to the endothelial-dependent vasodilator bradykinin was attenuated. Moreover, we have observed that endothelial denudation of the LAD by using an angioplasty balloon catheter prolongs the vasoconstriction effects of methacholine.

Although we have not carried out binding studies, the fact that both the EC50 and Emax values for methacholine were similar in vitro between control and ischemic-reperfused rings may exclude the possibility of an increased affinity for methacholine or an increased number of muscarinic receptors in infarct-related coronary arteries. Preservation of vascular smooth muscle reactivity after ischemia-reperfusion may depend on appropriate blood supply from vasa vasorum. This hypothesis, nonetheless, needs further investigation.

One could think that the modified response to both methacholine and bradykinin after ischemia-reperfusion was an artifact caused by the manipulation of the coronary artery necessary to place the silk snare occluder. However, we can rule out this possibility, because control animals were submitted to the same maneuver, placing a silk snare around the coronary artery but without occluding it. As can be seen in Figs. 3A and 5A, reproducibility of the response before and after placing the snare was good. In addition, pericoronary nerves are surrounded by a fat layer that protects them from damage (5, 6), and previous studies have demonstrated in pigs that chronic placement of Ameroid constrictors on left circumflex coronary arteries for 3 wk does not modify adrenergic innervation of circumflex-perfused myocardium (25).

Clinical Implications

This study indicates that infarct-related coronary arteries develop a significant and persistent smooth muscle-dependent vasoconstriction in vivo after adventitial muscarinic receptor stimulation. On the basis of the similarities in coronary innervation between pigs and humans (5, 14), our data suggest that, compared with normal coronary vessels, the infarct-related coronary artery would be more prone to develop sustained coronary constriction when exposed to a vagally mediated adventitial release of acetylcholine. This study supports that an altered coronary vascular reactivity to autonomic nervous influences may play a role on the genesis of recurrent ischemia in postinfarction patients. In clinical circumstances other than acute ischemia in which the endothelium is being damaged, as observed in patients with left ventricular hypertrophy (10), atherosclerosis (30), or coronary spastic angina (19), or after bypass surgery (20), the coronary vessel may also be more sensitive to autonomic influences.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
This study was supported by a grant from Marató TV3.


    FOOTNOTES
 

Address for reprint requests and other correspondence: J. Cinca, Servicio de Cardiología, Hospital de la Santa Creu i Sant Pau, St. Antoni M. Claret 167, 08025 Barcelona, Spain (E-mail: jcinca{at}hsp.santpau.es).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 

  1. Alfonso F, Segovia J, Goicolea J, Hernandez R, Fernandez-Ortiz A, Bañuelos C, and Macaya C. Angioscopic characteristics of coronary narrowing in patients with recurrent myocardial ischemia after myocardial infarction. Am J Cardiol 79: 1394-1396, 1997.[ISI][Medline]
  2. Babbitt DG, Virmani R, and Forman MB. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. Circulation 80: 1388-1399, 1989.[Abstract/Free Full Text]
  3. Bertrand ME, Lablanche JM, Tilmant PY, Thieuleux FA, Delforge MG, and Chahine RA. The provocation of coronary arterial spasm in patients with recent transmural myocardial infarction. Eur Heart J 4: 532-535, 1983.[Abstract/Free Full Text]
  4. Betriu A, Califf RM, Bosch X, Guerci A, Stebbins AL, Barbagelata A, Aylward PE, Vahanian A, Van de Werf F, Topol EJ, for the investigators GUSTOI. Recurrent ischemia after thrombolysis: importance of associated clinical findings. J Am Coll Cardiol 31: 94-102, 1998.[Abstract/Free Full Text]
  5. Cinca J, Carreño A, Mont L, Blanch P, and Soler-Soler J. Neurally mediated negative inotropic effect impairs myocardial function during cholinergic coronary vasoconstriction in pigs. Circulation 94: 1101-1108, 1996.[Abstract/Free Full Text]
  6. Cinca J, Mont L, Carreño A, Mourelle M, Rodes J, Domingo A, and Soler-Soler J. Coronary denervation attenuates coronary constriction induced by muscarinic receptor stimulation in pigs. Cardiovasc Res 32: 311-319, 1996.[Abstract/Free Full Text]
  7. Fernandez N, Martinez MA, Climent B, Garcia-Villalon AL, Monge L, Sanz E, and Dieguez G. Coronary reactivity to endothelin-1 during partial ischemia and reperfusion in anesthetized goats. Role of nitric oxide and prostanoids. Eur J Pharmacol 457: 161-168, 2002.[ISI][Medline]
  8. Figueras J, Cinca J, Valle V, and Rius J. Prognostic implications of early spontaneous angina after acute transmural myocardial infarction. Int J Cardiol 4: 261-272, 1983.[ISI][Medline]
  9. Fukai T, Koyanagi S, and Takeshita A. Role of coronary vasospasm in the pathogenesis of myocardial infarction: study in patients with no significant coronary stenosis. Am Heart J 126: 1305-1311, 1993.[ISI][Medline]
  10. Hamasaki S, Al Suwaidi J, Higano ST, Miyauchi K, Holmes DR Jr, and Lerman A. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 35: 1654-1660, 2000.[Abstract/Free Full Text]
  11. Hasan A and McDonough KH. Effects of short term ischemia and reperfusion on coronary vascular reactivity and myocardial function. Life Sci 57: 2171-2185, 1995.[ISI][Medline]
  12. Headrick JP, Angello DA, and Berne RM. Effects of brief coronary occlusion and reperfusion on porcine coronary artery reactivity. Circulation 82: 2163-2169, 1990.[Abstract/Free Full Text]
  13. Hearse DJ, Maxwell L, Saldanha C, and Gavin JB. The myocardial vasculature during ischemia and reperfusion: a target for injury and protection. J Mol Cell Cardiol 25: 759-800, 1993.[ISI][Medline]
  14. Hirsch EF and Borghard-Erdle AM. The innervation of the human heart. I. The coronary arteries and the myocardium. Arch Pathol 71: 384-407, 1961.[ISI][Medline]
  15. Jespersen CM. The prognostic significance of angina pectoris experienced during the first month following acute myocardial infarction. Clin Cardiol 20: 623-626, 1997.[ISI][Medline]
  16. Kim YD, Fomsgaard JS, Heim KF, Ramwell PW, Thomas G, Kagan E, Moore SP, Coughlin SS, Kuwahara M, Analouei A, and Myers A. Brief ischemia-reperfusion induces stunning of endothelium in canine coronary artery. Circulation 85: 1473-1482, 1992.[Abstract/Free Full Text]
  17. Kloner RA, Ganote CE, and Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54: 1496-1508, 1974.[ISI][Medline]
  18. Kouretas PC, Kim YD, Cahill PA, Myers AK, To LN, Wang YN, Sitzmann JV, and Hannan RL. Nonanticoagulant heparin prevents coronary endothelial dysfunction after brief ischemia-reperfusion injury in the dog. Circulation 99: 1062-1068, 1999.[Abstract/Free Full Text]
  19. Kugiyama K, Miyao Y, Sakamoto T, Kawano H, Soejima H, Miyamoto S, Yoshimura M, Ogawa H, Sugiyama S, and Yasue H. Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina. Am J Physiol Heart Circ Physiol 280: H264-H271, 2001.[Abstract/Free Full Text]
  20. Lockowandt U and Franco-Cereceda A. Off-pump coronary bypass surgery causes less immediate postoperative coronary endothelial dysfunction compared to on-pump coronary bypass surgery. Eur J Cardiothorac Surg 20: 1147-1151, 2001.[Abstract/Free Full Text]
  21. Martinez MA, Fernandez N, Monge L, Garcia-Villalon AL, Sanz E, and Dieguez G. Coronary responses to endothelin-1 and acetylcholine during partial coronary ischaemia and reperfusion in anaesthetized goats. Clin Sci (Lond) 103: 194S-197S, 2002.[Medline]
  22. Mehta JL, Nichols WW, Donnelly WH, Lawson DL, and Saldeen TGP. Impaired canine coronary vasodilator response to acetylcholine and bradykinin after occlusion-reperfusion. Circ Res 64: 43-54, 1989.[Abstract/Free Full Text]
  23. Mongiardo R, Finocchiaro ML, Beltrame J, Pristipino C, Lombardo A, Cianflone D, Mazzari MA, and Maseri A. Low incidence of serotonin-induced occlusive coronary artery spasm in patients with recent myocardial infarction. Am J Cardiol 78: 84-87, 1996.[ISI][Medline]
  24. Pearson PJ, Schaff HV, and Vanhoutte PM. Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circ Res 67: 385-393, 1990.[Abstract/Free Full Text]
  25. Roth DM, White FC, Mathieu-Costello O, Guth BD, Heusch G, Bloor CM, and Longhurst JC. Effects of left circumflex Ameroid constrictor placement on adrenergic innervation of myocardium. Am J Physiol Heart Circ Physiol 253: H1425-H1434, 1987.[Abstract/Free Full Text]
  26. Sueda S, Ochi N, Kawada H, Matsuda S, Hayashi Y, Tsuruoka T, and Uraoka T. Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. Am J Cardiol 83: 1186-1190, 1999.[ISI][Medline]
  27. Symons JD and Schaefer S. Na+/H+ exchange subtype 1 inhibition reduces endothelial dysfunction in vessels from stunned myocardium. Am J Physiol Heart Circ Physiol 281: H1575-H1582, 2001.[Abstract/Free Full Text]
  28. Tabata H, Mizuno K, Arakawa K, Satomura K, Shibuya T, Kurita A, and Nakamura H. Angioscopic identification of coronary thrombus in patients with postinfarction angina. J Am Coll Cardiol 25: 1282-1285, 1995.[Abstract]
  29. Tabernero A, Giraldo J, Vivas NM, Badia A, and Vila E. Endothelial modulation of {alpha}1-adrenoceptor contractile responses in the tail artery of spontaneously hypertensive rats. Br J Pharmacol 119: 765-771, 1996.[ISI][Medline]
  30. Tiefenbacher CP, Bleeke T, Vahl C, Amann K, Vogt A, and Kluber W. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation 102: 2172-2179, 2000.[Abstract/Free Full Text]
  31. Tsao PS, Aoki N, Lefer DJ, Johnson G, and Lefer AM. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 82: 1402-1412, 1990.[Abstract/Free Full Text]
  32. VanBenthuysen KM, McMurtry IF, and Horwitz LD. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest 79: 265-274, 1987.[ISI][Medline]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
F. Ikeno, K. Inagaki, M. Rezaee, and D. Mochly-Rosen
Impaired perfusion after myocardial infarction is due to reperfusion-induced {delta}PKC-mediated myocardial damage
Cardiovasc Res, March 1, 2007; 73(4): 699 - 709.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
95/1/81    most recent
00119.2003v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodríguez-Sinovas, A.
Right arrow Articles by Cinca, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodríguez-Sinovas, A.
Right arrow Articles by Cinca, J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.